Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemours (CC) Receivables (2016 - 2025)

Chemours (CC) has 12 years of Receivables data on record, last reported at $700.0 million in Q4 2025.

  • For Q4 2025, Receivables fell 14.63% year-over-year to $700.0 million; the TTM value through Dec 2025 reached $700.0 million, down 14.63%, while the annual FY2025 figure was $700.0 million, 14.63% down from the prior year.
  • Receivables reached $700.0 million in Q4 2025 per CC's latest filing, down from $997.0 million in the prior quarter.
  • Across five years, Receivables topped out at $1.2 billion in Q2 2022 and bottomed at $609.0 million in Q4 2022.
  • Average Receivables over 5 years is $840.0 million, with a median of $849.5 million recorded in 2023.
  • Peak YoY movement for Receivables: soared 56.02% in 2022, then decreased 21.49% in 2023.
  • A 5-year view of Receivables shows it stood at $679.0 million in 2021, then fell by 10.31% to $609.0 million in 2022, then increased by 2.13% to $622.0 million in 2023, then surged by 31.83% to $820.0 million in 2024, then fell by 14.63% to $700.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Receivables were $700.0 million in Q4 2025, $997.0 million in Q3 2025, and $1.0 billion in Q2 2025.